In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients

Monocytes (MO) from cancer patients present functional abnormalities, such as an altered secretion of soluble factors. In the present study, our aim was to evaluate the levels of interleukin-1β (IL-1β), tumour necrosis factor-alpha (TNF-α) and prostaglandin-E2 (PGE2) secreted in vitro by MO from lun...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Trejo, Y.G., Bordenave, R.H., Beviacqua, M., Rumi, L.S.
Formato:	JOUR
Materias:	Il-1β Lung cancer Monocytes Pge2 Tna-α cytokine interleukin 1beta lipopolysaccharide prostaglandin E2 tumor necrosis factor alpha article cell secretion cell stimulation clinical article controlled study cytokine release human human cell in vitro study lung cancer monocyte priority journal prostaglandin release
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_09546111_v95_n4_p243_Trejo
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

id	todo:paper_09546111_v95_n4_p243_Trejo
record_format	dspace
spelling	todo:paper_09546111_v95_n4_p243_Trejo2023-10-03T15:51:45Z In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients Trejo, Y.G. Bordenave, R.H. Beviacqua, M. Rumi, L.S. Il-1β Lung cancer Monocytes Pge2 Tna-α cytokine interleukin 1beta lipopolysaccharide prostaglandin E2 tumor necrosis factor alpha article cell secretion cell stimulation clinical article controlled study cytokine release human human cell in vitro study lung cancer monocyte priority journal prostaglandin release Monocytes (MO) from cancer patients present functional abnormalities, such as an altered secretion of soluble factors. In the present study, our aim was to evaluate the levels of interleukin-1β (IL-1β), tumour necrosis factor-alpha (TNF-α) and prostaglandin-E2 (PGE2) secreted in vitro by MO from lung cancer patients (LCP), spontaneously or after stimulation with lipopolysaccharide (LPS). Results showed that cytokine secretion was higher for MO from LCP than for MO from healthy controls, while in the 25% of the patients analysed, an absence of response to LPS treatment was found. © 2001 Harcourt Publishers Ltd. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_09546111_v95_n4_p243_Trejo
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-134
collection	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic	Il-1β Lung cancer Monocytes Pge2 Tna-α cytokine interleukin 1beta lipopolysaccharide prostaglandin E2 tumor necrosis factor alpha article cell secretion cell stimulation clinical article controlled study cytokine release human human cell in vitro study lung cancer monocyte priority journal prostaglandin release
spellingShingle	Il-1β Lung cancer Monocytes Pge2 Tna-α cytokine interleukin 1beta lipopolysaccharide prostaglandin E2 tumor necrosis factor alpha article cell secretion cell stimulation clinical article controlled study cytokine release human human cell in vitro study lung cancer monocyte priority journal prostaglandin release Trejo, Y.G. Bordenave, R.H. Beviacqua, M. Rumi, L.S. In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
topic_facet	Il-1β Lung cancer Monocytes Pge2 Tna-α cytokine interleukin 1beta lipopolysaccharide prostaglandin E2 tumor necrosis factor alpha article cell secretion cell stimulation clinical article controlled study cytokine release human human cell in vitro study lung cancer monocyte priority journal prostaglandin release
description	Monocytes (MO) from cancer patients present functional abnormalities, such as an altered secretion of soluble factors. In the present study, our aim was to evaluate the levels of interleukin-1β (IL-1β), tumour necrosis factor-alpha (TNF-α) and prostaglandin-E2 (PGE2) secreted in vitro by MO from lung cancer patients (LCP), spontaneously or after stimulation with lipopolysaccharide (LPS). Results showed that cytokine secretion was higher for MO from LCP than for MO from healthy controls, while in the 25% of the patients analysed, an absence of response to LPS treatment was found. © 2001 Harcourt Publishers Ltd.
format	JOUR
author	Trejo, Y.G. Bordenave, R.H. Beviacqua, M. Rumi, L.S.
author_facet	Trejo, Y.G. Bordenave, R.H. Beviacqua, M. Rumi, L.S.
author_sort	Trejo, Y.G.
title	In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
title_short	In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
title_full	In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
title_fullStr	In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
title_full_unstemmed	In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
title_sort	in vitro secretion of cytokines and prostaglandin-e2 by monocytes from lung cancer patients
url	http://hdl.handle.net/20.500.12110/paper_09546111_v95_n4_p243_Trejo
work_keys_str_mv	AT trejoyg invitrosecretionofcytokinesandprostaglandine2bymonocytesfromlungcancerpatients AT bordenaverh invitrosecretionofcytokinesandprostaglandine2bymonocytesfromlungcancerpatients AT beviacquam invitrosecretionofcytokinesandprostaglandine2bymonocytesfromlungcancerpatients AT rumils invitrosecretionofcytokinesandprostaglandine2bymonocytesfromlungcancerpatients
_version_	1807314485487075328

In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients

Ejemplares similares